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Regulation of autophagy and the ubiquitin–
proteasome system by the FoxO transcriptional
network during muscle atrophy
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Stresses like low nutrients, systemic inﬂammation, cancer or infections provoke a catabolic
state characterized by enhanced muscle proteolysis and amino acid release to sustain liver
gluconeogenesis and tissue protein synthesis. These conditions activate the family of Fork-
head Box (Fox) O transcription factors. Here we report that muscle-speciﬁc deletion of FoxO
members protects from muscle loss as a result of the role of FoxOs in the induction of
autophagy–lysosome and ubiquitin–proteasome systems. Notably, in the setting of low
nutrient signalling, we demonstrate that FoxOs are required for Akt activity but not for mTOR
signalling. FoxOs control several stress–response pathways such as the unfolded protein
response, ROS detoxiﬁcation, DNA repair and translation. Finally, we identify FoxO-dependent
ubiquitin ligases including MUSA1 and a previously uncharacterised ligase termed SMART
(Speciﬁc of Muscle Atrophy and Regulated by Transcription). Our ﬁndings underscore the
central function of FoxOs in coordinating a variety of stress-response genes during catabolic
conditions.
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E
nvironmental transformations have selected for species
that are able to quickly and efﬁciently regulate their
physiology. Under stress conditions, mammalian cells
activate compensatory mechanisms to adapt themselves to new
situations. Depending on the stimuli, the adaptive response either
require minor and fast metabolic changes or involves major and
sustained adjustments that need transcription-dependent adapta-
tions. Muscles are the largest protein reservoir in the body and
serve as a source of amino acids that can be used for energy
production by various vital organs (including heart, liver and
brain) during catabolic periods, such as in cancer, sepsis, burn
injury, heart failure and AIDS1. However, excessive and sustained
protein degradation in skeletal muscle, and the resulting muscle
loss (cachexia), is highly detrimental and can lead to death.
Moreover, excessive loss of muscle mass is a poor prognostic
index and impairs the efﬁcacy of many different therapeutic
treatments. Thus, cachexia ultimately aggravates diseases and
increases morbidity and mortality.
In eukaryotic cells, most proteins are degraded via two
proteolytic systems: the ubiquitin–proteasome and the
autophagy–lysosome. In skeletal and cardiac muscles the two
systems are coordinately regulated to remove proteins and
organelles in atrophying cells2,3. Muscle atrophy requires a
transcription-dependent programme to regulate a group of genes
that are commonly up or downregulated in atrophying muscles
during different catabolic conditions and that are named atrophy-
related genes or atrogenes1,4–8. These genes encode enzymes that
catalyse important steps in autophagy–lysosome, ubiquitin–
proteasome, unfolded protein response, ROS detoxiﬁcation,
DNA repair, mitochondrial function and energy balance
pathways. The transcription factors that orchestrate this
complex gene network have been the focus of active investigation.
The two atrogenes with the greatest induction are two muscle-
speciﬁc ubiquitin ligases, namely atrogin1/MAFbx and MuRF14,5.
Mice lacking these two enzymes are partially resistant to muscle
atrophy induced by denervation4. However, the action of these two
ubiquitin ligases cannot account for the degradation of all muscle
proteins. A number of additional unknown ubiquitin ligases (E3s)
are presumably activated during atrophy to promote the clearance
of myoﬁbrillar and soluble proteins and/or to limit anabolic
processes. We have recently established that these atrophy-related
ubiquitin ligases, as well as protein breakdown in general, are
blocked by the growth-promoting IGF1/AKT pathway8,9. Members
of the Forkhead Box (Fox) O family (FoxO1, 3 and 4), downstream
targets of AKT, were identiﬁed as the main transcription factors
regulating atrogin1 expression8. Importantly, we have also found
that FoxO3 regulates autophagy coordinating the proteasomal-
dependent removal of proteins with the autophagy-dependent
clearance of organelles2,10. The use of FoxO1 knockout mice has
established a role in muscle protein homeostasis showing partial
protection from muscle loss during chronic kidney disease11.
FoxO1 deﬁciency was associated with partial reduction in the
expression of atrogin1, MuRF1 and the lysosomal enzyme,
Cathepsin-L11,12. These studies linking FoxOs and muscle
wasting prompted us to explore more fully the speciﬁc function
of the entire FoxO family in skeletal muscle maintenance/loss and
the potential for functional redundancy among the FoxO members
and to illuminate the atrogene expression network focused on the
identiﬁcation of novel FoxO-dependent atrophy-related genes.
Here we show that speciﬁc deletion of FoxOs in skeletal
muscles prevents muscle loss and force decline in response to
fasting and denervation because the FoxO family is required for
the induction of several atrophy-related genes. Moreover, we
identify a novel ubiquitin ligase, named SMART (Speciﬁc of
Muscle Atrophy and Regulated by Transcription), that plays a
critical role in protein ubiquitination after denervation.
Results
Generation of a triple FoxO1,3,4 muscle-speciﬁc knockout.
Since muscle wasting requires a transcriptional-dependent pro-
gramme to induce the expression of a subset of genes and because
FoxO family is sufﬁcient to induce muscle atrophy, we generated
mice with adult skeletal muscle-speciﬁc deletion of all three FoxO
family members to unravel the role of this family in gene reg-
ulation and muscle adaptation during catabolic conditions. To
that end, FoxO1/3/4-ﬂoxed mice (FoxO1/3/,4f/f) were crossed with
a transgenic line expressing Cre recombinase under the control of
muscle-speciﬁc MLC1f promoter (hereafter referred to as
FoxO1,3,4 / ). PCR analysis conﬁrmed deletion of the ﬂoxed
sequence from genomic DNA extracted from skeletal muscle
(Fig. 1a). Quantitative reverse transcription–PCR (RT–PCR) and
Western blot analyses showed a signiﬁcant decrease or elimina-
tion of FoxO1, FoxO3 and FoxO4 transcripts and proteins,
respectively (Fig. 1b,c). Since FoxO4 is mainly expressed in stri-
ated muscles13, while FoxO1 and 3 are expressed in a variety of
tissues, the traces of FoxO1 and 3 messenger RNAs (mRNAs)
come from endothelial, ﬁbroblasts, macrophages and blood cells.
Thus, we conﬁrm a genetic model of muscle-speciﬁc inhibition of
FoxO1,3,4 family.
Triple FoxO1,3,4 deletion in muscle does not affect ﬁbre type.
FoxO1,3,4 / mice were indistinguishable in gross appearance
from age-matched control FoxO1,3,4f/f mice and histological
analysis of adult muscles revealed normal muscle architecture and
absence of myopathic features such as centrally nucleated ﬁbres
(Fig. 1d). Succinate dehydrogenase staining showed no major
changes in distribution of small b-oxidative mitochondrial rich
versus large glycolytic mitochondrial poor ﬁbres (Fig. 1e). Since
FoxOs are important for glucose homeostasis in liver, we mon-
itored glycogen levels in muscle. PAS staining revealed an almost
identical distribution of glycogen stores (Fig. 1f). Analyses of
myosin heavy chain expression (Fig. 1g) and distribution (Fig. 1h)
did not reveal any signiﬁcant difference between wild-type and
FoxO1,3,4 knockout mice. These ﬁndings support the view that
FoxO deﬁciency does not affect ﬁbre type determination and
basal glucose homeostasis and is permissive for normal muscle
function. Quantiﬁcation of cross-sectional area of fast muscles
(Tibialis Anterior (TA) and Gastrocnemius) did not show any
signiﬁcant difference between knockout and controls (Fig. 1i,
Supplementary Fig. 1).
FoxO inhibition prevents muscle loss and weakness. To further
characterize the role of FoxO1,3,4 in skeletal muscles, we then
analysed the phenotype of FoxO1,3,4 / mice under conditions
of muscle wasting. Initially, we used fasting as a model of muscle
loss since it is an established condition that induces nuclear
translocation of FoxO members and their binding to target pro-
moters2,8,14 (Supplementary Fig. 2) and we compared FoxO1,3,4
null muscles with controls. Importantly, FoxO1,3,4 knockout
mice were completely spared from muscle loss after fasting
(Fig. 2a, Supplementary Fig. 3). To understand whether sparing of
muscle mass is also functionally relevant, we measured muscle
force in living animals. While control fasted animals became
signiﬁcantly weaker than fed ones, FoxO1,3,4 / gastrocnemius
muscles did not loose strength after fasting (Fig. 2b). Importantly
the comparison of force/frequency curve of fasted wild-type
versus fasted FoxO1,3,4 null muscle underlined the important
protection achieved by the absence of FoxO family when
nutrients are low or absent (Fig. 2c). These ﬁndings conﬁrm
that the absence of FoxO members prevents atrophy and
profound weakening. To explain this profound effect on
sparing force and muscle mass, we monitored the level of the
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contractile protein, myosin, when nutrients are removed. As
expected, fasting induced an important reduction of myosin
content in controls, while FoxO1,3,4 knockout were completely
protected (Supplementary Fig. 4a). The maintenance of myosins
in knockout is consequent to inhibition of protein ubiquitination
(Supplementary Fig. 4b-c).
FoxOs are critical for autophagy and protein ubiquitination.
To explore the basis for sparing of muscle mass in absence of
nutrients, we audited the signalling pathways linked to Insulin/
IGF1 and energy. Interestingly, Akt, S6K and S6 phosphorylation,
both in fed and fasted muscles, were reduced in knockout mice,
while phosphorylation of 4EBP1, the other mTORC1 down-
stream target, was increased in FoxO-deﬁcient TA muscle
(Fig. 2d, Supplementary Fig. 5a). The energy–stress sensor AMPK
and its downstream target ACC did not signiﬁcantly differ from
controls in fed and fasting conditions (Fig. 2d). Therefore, the
changes in the pathways downstream energy and insulin/nutri-
ents do not match with the important sparing of muscle mass in
knockout mice when nutrients are absent.
Since the absence of nutrients is a potent stimulus for
autophagy-dependent degradation and since FoxO is an inducer,
while mTOR is a suppressor of autophagy–lysosome system, we
checked the status of this system in FoxO1,3,4 / mice. We
monitored LC3 lipidation, LC3-positive vesicles and autophagy
ﬂux in FoxO1,3,4f/f and FoxO1,3,4  / mice. Fasting induced
LC3 lipidation (Fig. 2e, Supplementary Fig. 5b) and vesicles
formation (Fig. 2f) in control but not in FoxO-deﬁcient muscles.
Autophagy ﬂux was monitored by treating animals with
colchicine, an established inhibitor of microtubule-mediated
delivery of autophagosome to lysosome15. The inhibition of
autophagosome fusion to lysosomes led to accumulation of
lipidated LC3 in controls but not in FoxO1,3,4-deﬁcient muscles
(Fig. 2g). In conclusion, during fasting, despite mTOR signalling
being partially inhibited, autophagy enhancement is completely
blocked in FoxO1,3,4 / muscle.
Absence of nutrients activates also the ubiquitin–proteasome
system, leading to an increase of protein ubiquitination and,
consequently, in proteasome-dependent degradation. Fasting
resulted in an increase in both lysine-48 and lysine-63 poly-
ubiquitinated proteins (Supplementary Fig. 4b,c), conﬁrming an
activation of the ubiquitination process in controls. Importantly,
this increase was totally abolished in FoxO1,3,4 knockout mice.
Half of the atrophy-related genes are under FoxO regulation.
Since muscle atrophy is characterized by transcription-dependent
regulation of atrogenes (atrophy-related genes) and FoxO deﬁ-
ciency protects from muscle loss, we sought to identify genes
under FoxO regulation. Gene expression proﬁles of fed and fasted
control and FoxO1,3,4 / muscles were compared with identify
genes with blunted induction in the fasted FoxO1,3,4 / mice
relative to controls. Cross-referencing with the list of known
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Figure 1 | Deletion of FoxOs is permissive for normal muscle function. (a) PCR analysis with genomic DNA from FoxO1,3,4f/f and FoxO1,3,4 /
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(f) PAS staining (Scale bar, 1mm) showing normal morphology, ﬁbre type and glycogen of FoxO1,3,4 / gastrocnemius muscle. (g) SDS–PAGE and
(h) immunohistochemistry analysis of myosin heavy chain type I, IIA, IIB and IIX proteins in gastrocnemius muscles showing no differences between
FoxO1,3,4 / and FoxO1,3,4f/f mice. Data are representative of three independent experiments. (i) Frequency histograms showing the distribution of
cross-sectional areas (mm2) in TA of FoxO1,3,4f/f (white bars) and FoxO1,3,4 / (black bars) ﬁbres, n¼4, each group. Data are shown as mean±s.e.m.
Error bars indicate s.e.m. **Po0.01 (Student’s t-test).
NATURE COMMUNICATIONS | DOI: 10.1038/ncomms7670 ARTICLE
NATURE COMMUNICATIONS | 6:6670 |DOI: 10.1038/ncomms7670 |www.nature.com/naturecommunications 3
& 2015 Macmillan Publishers Limited. All rights reserved.
atrogenes7, these analyses revealed that 29 of the 63 atrophy-
related genes require FoxO for their normal induction during
fasting (Fig. 2h, Supplementary Fig. 10). Quantitative RT–PCR
conﬁrmed that 26 of the atrophy-related genes were not induced
in FoxO null muscles during fasting (Fig. 3). Consistent with
morphology and force measurements, the induction of genes
involved in protein breakdown was completely blocked in
knockout mice. In fact both the ubiquitin system including the
ubiquitin ligases (Atrogin1 and MuRF1), the ubiquitin gene
(UBC), the de-ubiquitinating enzyme (USP14), the E3/E4 enzyme
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(Ube4b), several proteasome subunits (Psme4/PA200, Psma1,
Psmc4/Rpt3 and Psmd11/Rpn6) as well as the autophagy-related
genes (LC3, Gabarapl, Bnip3, Cathepsin L and p62/SQSTM1)
were completely blocked in FoxO1,3,4 / mice. Other pathways
that are inhibited in knockout muscles are related to the unfolded
protein response (ATF4 and GADD34), protein synthesis (4EBP1
and eIF4g), transcription regulators that negatively control
Smad2/3 (TGIF) or positively affect Myc (MAX), DNA repair/
chromatin remodelling (GADD45a) and ribosome transcription/
maturation/assembly (Nucleolin). Expression of genes that are
related to oxidative stress were more variable; Nrf2/Nfe2l2 was not
affected by FoxO deletion, while Thioredoxin was suppressed and
Metallothionein1 was signiﬁcantly induced in the absence of
FoxO factors.
Western blot analyses of some atrogenes involved in autophagy
(p62, Gabarapl and Bnip3), chromatin remodelling/DNA repair
(GADD45a), protein synthesis (4EBP1) and ubiquitin–
proteasome conﬁrmed their upregulation during fasting in
control animals but not in FoxO1,3,4 knockout (Supplementary
Fig. 6).
Inducible FoxOs loss phenocopies the conditional knockout.
To corroborate our ﬁndings, we also explored the impact of
somatic deletion of FoxO in the adult via a tamoxifen-inducible
muscle-speciﬁc FoxO knockout model. Following documentation
of tamoxifen-induced deletion of FoxOs (Supplementary Fig. 7),
we assessed muscle loss during fasting by monitoring muscle
mass and muscle force. Similar to the above, we found that
somatic deletion of FoxO1,3,4 prevented muscle loss (Fig. 4a) and
muscle weakness during fasting (Fig. 4b). Consistent with the
conditional knockout, Akt activation and LC3 lipidation was
reduced in FoxO knockout when compared with controls
(Fig. 4c). Autophagy ﬂux measurements conﬁrmed that FoxOs
are required for autophagy induction (Fig. 4d). We then tested
whether inhibition of FoxO members in adulthood blocked the
activation of the atrogenes. Indeed, we conﬁrmed most of the data
obtained by the conditional FoxO1,3,4 knockout (Supplementary
Fig. 8). The fact that two different FoxO1,3,4 knockout mice
resulted in comparable biological effects strongly supports the
conclusion that the FoxO family is a master regulator of the
atrophy programme under low nutrient conditions.
FoxOs directly regulate atrophy-related genes. To determine
whether the regulation of these atrogenes requires direct binding
of FoxO transcription factors to their promoters and to identify
the binding sites we performed chromatin immunoprecipitation
(ChIP) experiments on fasted muscles of FoxO1,3,4f/f. We also
used FoxO1,3,4 / as a negative control to validate the speci-
ﬁcity of the immunoprecipitation. FoxO3 was recruited to almost
all of the promoters so far analysed (Fig. 4e). We then asked
whether the activation of these genes is strictly dependent on
FoxO3 or whether other FoxO members can bind the same
promoter region. We could immunoprecipitate FoxO1 but not
FoxO4 because we did not ﬁnd any ChIP grade antibody that was
speciﬁc for FoxO4 without crossreacting with other FoxOs.
Interestingly, FoxO1 was found to be signiﬁcantly recruited to
some promoters such as MuRF1, p62, Cathepsin L and TGIF
(Fig. 4f). This ﬁnding suggests that regulation of some genes is
shared by different FoxO members, while others preferentially
recruit FoxO3.
FoxOs are required for denervation-dependent atrophy. To
further determine whether the role of FoxO1,3,4 is critical in
different catabolic conditions, we then used denervation as
another model of muscle atrophy. Quantiﬁcation of ﬁbre size
revealed that FoxO-deﬁcient muscles were partially protected
from atrophy (Fig. 5a, Supplementary Fig. 9). When we mon-
itored muscle force, we conﬁrmed the histological data. Soleus
muscle of FoxO1,3,4 knockout mice generated higher strength
than controls in the basal condition (Fig. 5b) and FoxO deletion
was able to partially prevent weakness and maintain the same
force of innervated FoxO1,3,4f/f (Fig. 5b,c). The decrease of force
in denervated FoxO1,3,4-deﬁcient soleus muscle is related to the
presence of FoxO proteins in type I ﬁbres that can promote
protein breakdown in these myoﬁbres. It is important to
emphasize that the type I ﬁbres express FoxOs because the pro-
moter (MLC1f) driving the expression of Cre recombinase is
active in type II ﬁbres and not in type I ﬁbres. However, com-
parison of the force/frequency curves of denervated wild-type
versus denervated FoxO1,3,4 null soleus muscles underlines the
important protection conferred by the absence of FoxO family
when nerve is damaged (Fig. 5c). Analyses of signalling conﬁrmed
the downregulation of P-AKT in knockout muscles. Denervation
induced an increase of total and phospho-4EBP1 protein in
FoxO1,3,4f/f but not in FoxO1,3,4 / muscle (Fig. 5d). The
changes in the phosphorylation of 4EBP1 were not ascribed to
activation of the cellular energy sensor AMPK, revealed by
checking its phosphorylation level or the downstream target
ACC. In contrast to fasting, the autophagy system was mildly
affected by the absence of FoxOs. Indeed, LC3 lipidation was
slightly decreased in FoxO1,3,4 / compared with controls after
denervation (Fig. 5e). However, and consistent with fasting, the
transcriptional upregulation of p62/SQSTM1 in denervated
muscles was greatly attenuated (Figs 5e and 6). When we tested
the expression of the different atrophy-related genes, we found
only a partial suppression of these genes (Fig. 6). Interestingly, the
lists of FoxO-dependent genes during denervation and fasting do
not completely overlap (Supplementary Fig. 10). For instance, the
Figure 2 | Deletion of FoxOs prevents muscle loss and weakness during fasting. (a) Frequency histograms of cross-sectional areas (mm2) of FoxO1,3,4f/f
(black bars) and FoxO1,3,4 / (magenta bars) ﬁbres in fed (upper panel) and fasted (lower panel) conditions, n¼4, each group. (b) Force measurements
preformed in vivo on gastrocnemius showed that FoxO1,3,4 / muscles preserve maximal tetanic force after fasting; n¼6 muscles in each group.
(c) Force/frequency curve of starved gastrocnemius muscle underlines the important protection achieved by the absence of FoxOs; n¼6 muscles in each
group. (d) Immunoblot of protein extracts from gastrocnemius muscles. Phosphorylation of AKTand S6 is reduced in fed and starved FoxO1,3,4 / muscles
when compared with controls. Data are representative of three independent experiments. (e) Immunoblot analysis of p62 and LC3 in homogenates of
gastrocnemius muscles from fed and starved FoxO1,3,4 / or controls. Fasting did not induce LC3 lipidation and p62 upregulation in FoxO-deﬁcient
muscles. Data are representative of three independent experiments. (f) Quantiﬁcation of GFP–LC3-positive vesicles in FoxO1,3,4f/f and FoxO1,3,4 / TA
muscles; n¼4 muscles in each group (g) Autophagy ﬂux is not increased in FoxO-deﬁcient TA muscles. Inhibition of autophagy–lysosome fusion by
colchicine treatment induces accumulation of LC3II band in starved control but not in starved FoxO1,3,4 / muscles. Upper panel: immunoblot analysis of
gastrocnemius homogenates. Lower panel: quantiﬁcation of LC3 lipidation. n¼4 muscles in each group (h) The scheme shows the overlap between
FoxO-dependent genes, identiﬁed by gene expression proﬁling of fed (n¼4) and fasted (n¼4) muscles from FoxO1,3,4f/f and FoxO1,3,4 / and
atrophy-related genes or atrogenes. The data in the graphs are shown as mean±s.e.m. Error bars indicate s.e.m. *Po0.05, **Po0.01 (Student’s t-test).
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ROS detoxifying factor, Nrf2/Nfe2l2, was not affected by FoxO
deletion in fasting, while it was less activated in denervated
FoxO1,3,4 null muscles. Therefore, FoxO family members are
necessary for muscle loss but their involvement in the atrophy
programme depends on the catabolic condition.
FoxO members are redundant. Since all FoxO members are
expressed in muscles and are under AKT regulation, we investi-
gated whether they play synergistic roles or have speciﬁc
functions. To address this point, we generated muscle-speciﬁc
individual FoxO knockout animals. We used denervation as a
model of muscle atrophy. Deletion of FoxO1 did not protect from
muscle atrophy (Fig. 7a, Supplementary Fig. 11). However the
presence of FoxO1 is required for the optimal induction of several
atrophy-related genes including MuRF1, Cathepsin L, Gabarap L,
GADD45a and TGIF (Supplementary Fig. 12).
Inhibition of FoxO3 led to a small but signiﬁcant protection
from denervation-induced muscle atrophy (Fig. 7b). The
protection was mainly achieved in oxidative ﬁbres
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(Supplementary Fig. 13). Interestingly, when we checked the level
of gene expression we found that FoxO4 was strongly down-
regulated in FoxO3 / mice (Supplementary Fig. 14). Optimal
expression of Gabarapl, 4EBP1, Maf, Gadd45a, Pfkf3 and Txn1
requires the presence of FoxO3 (Supplementary Fig. 14).
Ablation of FoxO4 did not signiﬁcantly protect myoﬁbres from
atrophy after denervation (Fig. 7c and Supplementary Fig. 15)
and did not reduce the expression of any atrogenes with the
exception of a slight reduction of GADD45a and Thioredoxin
(Supplementary Fig. 16).
FoxOs regulate a novel set of ubiquitin ligases. To explain why
inhibition of FoxO3 slightly reduced muscle atrophy despite the
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limited effects on induction of the atrophy-related genes, we
looked for novel genes that might be involved in protein break-
down and that are selectively regulated by this FoxO member in
denervated muscles. When we looked at the gene expression
proﬁles in fasted muscles of FoxO1,3,4 knockout mice, we noticed
a group of ubiquitin ligases that were upregulated in FoxO1,3,4f/f
but not in FoxO1,3,4 / mice. This set of ubiquitin ligases
includes MUSA1, a novel E3, that we have recently found to be
critical in muscle atrophy16, Fbxo31, an E3 of SCF family involved
in cyclinD degradation and tumour suppression17, Itch, a HECT-
type ubiquitin ligase that regulates the half-life of transcription
factors such as JunB, c-Jun and p6318, and, ﬁnally, Fbxo21, a gene
of unknown function but that contains an F-box motif and that
we re-named SMART.
By quantitative RT–PCR, we could validate that upregulation
of MUSA1, SMART and FbxO31, but not Itch, is blunted or
partially blocked in fasted or denervated muscles of FoxO1,3,4,
knockout mice (Fig. 7d,e). To further prove that the FoxO family
is sufﬁcient for their expression, we overexpressed FoxO3 in
myotubes and we checked the expression of these E3s.
Interestingly, FoxO3 was sufﬁcient to induce the expression of
MUSA1 but not the other ubiquitin ligases (Supplementary
Fig. 17). We then analysed the promoter regions of these
genes and checked whether endogenous FoxO1 and FoxO3
directly bind these regions. ChIP experiments on fasted muscle
conﬁrmed that both FoxO1 and FoxO3 bind to the promoters
of MUSA1 and SMART (Fig. 7f,g). However, we did not ﬁnd
any signiﬁcant recruitment of FoxOs on Itch and Fbxo31
promoters (Fig. 7f,g).
We checked whether expression of these ubiquitin ligases
was suppressed in denervated muscles of the single FoxO
knockout mice. Interestingly, FoxO3 deletion completely
blunted the induction of SMART while ablation of the other
FoxO members did not elicit any effect on the upregulation
of these ubiquitin ligases (Fig. 7h–j). Therefore, FoxO3 is
the main regulator of SMART in denervated muscles
and inhibition of SMART may explain the partial protection
of FoxO3 null muscles after denervation (Fig. 7b and
Supplementary Fig. 13).
SMART is a novel E3 ligase required for muscle atrophy. IP
experiments conﬁrmed that SMART forms an SCF complex with
Skp1, Cullin1 and Roc1 (Fig. 8a) and therefore belongs to the SCF
family of E3 ligases. To conﬁrm the role of SMART in promoting
atrophy during denervation, we knocked down SMART in TA
in vivo. Four different short hairpin RNAs (shRNAs) have been
tested to speciﬁcally reduce SMART protein levels
(Supplementary Fig. 18a), three of which efﬁciently knocked
down SMART. Next, we transfected oligo 4 into innervated and
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denervated muscles. These shRNAs did not affect the expression
of the other atrophy-related ubiquitin ligases, MUSA, MuRF1 and
atrogin1 both at protein and mRNA level (Supplementary
Fig. 18b, Fig. 8b). Importantly, SMART inhibition signiﬁcantly
protected denervated muscles from atrophy (Fig. 8c). This spar-
ing is due to the fact that by blocking SMART we greatly reduced
protein ubiquitination in denervated muscles (Fig. 8d,
Supplementary Fig. 18c). Therefore, we have identiﬁed SMART as
an additional critical gene whose upregulation is required for
atrophy, yet must be carefully controlled to avoid excessive pro-
tein breakdown. In conclusion, our ﬁndings underline the
concept that FoxO members are the master regulatory factor for
protein homeostasis during catabolic conditions.
Discussion
FoxOs are involved in a variety of biological process such as
autophagy, apoptosis, ROS detoxiﬁcation, glucose metabolism,
DNA repair, cell cycle, stem cell maintenance and longevity19,20.
Our work and that of others has shown that muscle atrophy is
regulated by a transcription-dependent process that requires the
expression of atrogenes. The transcription factors that orchestrate
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this complex gene network are still largely unknown but our
ﬁndings highlight the FoxO family as one of the most important
regulators. The ﬁnding that different genes involved in different
pathways, including several ubiquitin ligases and proteasome
subunits, are under FoxO regulation, is an important step towards
the understanding of FoxO-dependent adaptation to stress such
as nutritional deprivation. For instance, one of the most
important adaptive responses that is induced to maintain
cellular survival under stress conditions is autophagy21. Our
data from different knockout mice highlight the concept that
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FoxOs are required to sustain autophagic ﬂux under low nutrients
and dominate mTOR signalling on autophagy regulation. It is
worth underlining that FoxO deletion does not affect basal
autophagic ﬂux and indeed the knockout mice do not show any
overt pathological phenotype that may resemble the features of
muscle-speciﬁc Atg7 knockout mice22. This is in contrast with the
phenotype of TSC1 knockout mice, which display hyperactivation
of the mTORC1 pathway leading to inhibition of basal
autophagic ﬂux and resulting in a myopathic phenotype23.
Altogether these ﬁndings suggest that basal autophagy is
controlled by mTOR and not by FoxOs, while induction and
maintenance of high autophagic ﬂux for hours/days is
entirely dependent on the FoxO family. Indeed, deletion of
FoxO both in a muscle-speciﬁc manner and in an inducible
muscle-speciﬁc manner resulted in suppression of autophagy
during fasting in face of mTOR inhibition. Importantly, the
demonstration that deletion of a single FoxO member is not
sufﬁcient to prevent muscle loss and autophagy activation
supports the conclusion that there is signiﬁcant redundancy
among family members.
Among the family members, FoxO3 deletion is less compen-
sated by the other factors suggesting that FoxO3 is the most
critical factor for the atrophy programme. Interestingly, the
sparing of muscle mass in the single knockout is not only due
to an effect on the classical ubiquitin ligase atrogin1 and MuRF1
but is due to FoxO action on a different set of ubiquitin ligases.
Indeed we have identiﬁed a group of novel ubiquitin ligases
that are regulated by FoxO. Among the novel E3s, we identiﬁed
a gene that encodes an F-box protein (FbxO21) whose
function was completely unknown and that we named SMART.
Gain- and loss-of-function experiments showed that FoxOs are
required for SMART regulation and ChIP experiments
revealed that FoxO1 and FoxO3 are recruited on the promoter.
However, deletion of FoxO3 and not of FoxO1 completely
blunted SMART induction after denervation, suggesting that
SMART is mainly under FoxO3 regulation. However, when we
overexpressed FoxO3 only MUSA1 was induced, suggesting that
FoxO3 is required for SMART induction but not sufﬁcient and
that other transcription factors are therefore involved in its
regulation.
MUSA1 is a novel ubiquitin ligase that we found to be critical
for muscle atrophy during denervation and fasting. Indeed,
RNAinterference (RNAi)-mediated inhibition of MUSA1 expres-
sion, in vivo, in denervated muscles, spares muscle mass.
Conversely, excessive MUSA1 induction exacerbates muscle loss
causing muscle cachexia16. Expression of MUSA1 is regulated by
Smad transcription factors16 in denervated muscles. The
possibility that Smads and FoxO cooperate to promote MUSA1
expression is consistent with the ﬁnding that Smads require FoxO
for the regulation of speciﬁc target genes. Therefore, it is possible
that Smads are the partners of FoxO and both are required for the
optimal activation of the atrogenes, at least during denervation.
However, during fasting most of the atrophy-related genes are
completely dependent on FoxO. In addition to the FoxO-
dependent regulation of different ubiquitin ligases, it is
important to emphasize that several proteasome subunits,
ubiquitin C and the de-ubiquitinating enzyme USP14 are also
controlled by FoxOs. These genes are critical in several steps of
ubiquitination and proteasome-dependent degradation and might
have an important role in control of protein degradation. For
instance, it has recently been reported that expression of PSMD11
in human stem cells is sufﬁcient to increase proteasome assembly
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muscle ﬁbres were co-transfected with bicistronic expressing vectors that encode shRNAs against SMART (oligo 4) or scramble and GFP and denervated.
Two weeks later cross-sectional area of transfected ﬁbres, identiﬁed by GFP ﬂuorescence, was measured. n¼ 6 muscles for each group. (d) Densitometric
quantiﬁcation of polyubiquitinated proteins in muscle extracts transfected with shRNAi against SMART or scramble. Values are normalized to GAPDH
and expressed as fold increase of fed control mice. n¼ 3 muscles for each group. Data are shown as mean±s.e.m. Error bars indicate s.e.m. *Po0.05,
**Po0.01 (Student’s t-test). con, control; den, denervated; IB, immunoblotting.
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and activity and, in C. elegans, a PSMD11 homologue induces
resistance to oxidative stress and poly-glutamine aggregation and
extends lifespan24.
Further work is needed to understand the interplay between
the autophagy–lysosome and ubiquitin–proteasome systems in
the context of different catabolic or even anabolic conditions,
however, this work sets out the fundamentals for understanding
the regulation of proteostasis in striated muscles.
Methods
Generation of muscle-speciﬁc FOXO1,3,4 knockout mice. Mice bearing
FoxO1,3,4-ﬂoxed alleles (FoxO1,3,4f/f) 25 were crossed with transgenic mice
expressing Cre either under the control of a Myosin Light Chain 1 fast promoter
(MLC1f-Cre)2,26 or with transgenic expressing a Cre-ER driven by human skeletal
actin promoter27. Genomic DNA isolated from FoxO1,3,4f/f mice was subjected to
PCR analysis. Cre-mediated recombination was conﬁrmed by PCR with genomic
DNA from gastrocnemius muscles using the primers Cre forward: 30-CACCAGCC
AGCTATCAACTCG-50 and Cre reverse: 30-TTACATTGGTCCAGCCACCAG-50 .
Tamoxifen-inducible Cre was activated by special tamoxifen diet (Tam400/Cre-ER
Harlan) or by i.p. Tamoxifen injection.
The genotyping analysis for each speciﬁc FoxO member was performed with
the combination of the following primers: FoxO1 forward: 30-GCT TAG AGC
AGA GAT GTT CTC ACA TT-50 , FoxO1 reverse1: 30-CCA GAG TCT TTG TAT
CAG GCA AAT AA-50, FoxO1 reverse2: 30-CAA GTC CAT TAA TTC AGC ACA
TTG A-50 , FoxO3 forward1: 30-AGA TTT ATG TTC CCA CTT GCT TCC T-50 ,
FoxO3 forward2: 30-TGC TTT GAT ACT ATT CCA CAA ACC C-50, FoxO3
reverse: 30-ATT CCT TTG GAA ATC AAC AAA ACT-50 , FoxO4 forward1:
30- TGA GAA GCC ATT GAA GAT CAG A-50 , FoxO4 forward2: 30-CTA CTT
CAA GGA CAA GGG TGA CAG-50 , FoxO4 reverse: 30-CTT CTC TGT GGG AAT
AAA TGT TTG G-50 .
Animals and in vivo transfection experiments. Animals were handled by spe-
cialized personnel under the control of inspectors of the Veterinary Service of the
Local Sanitary Service (ASL 16—Padova), the local ofﬁcers of the Ministry of
Health. Mice were housed in individual cages in an environmentally controlled
room (23 C, 12-h light–dark cycle) with ad libitum access to food and water. All
procedures are speciﬁed in the projects approved by the Italian Ministero Salute,
Ufﬁcio VI (authorization numbers C65) and by the Ethics Committee of the
University of Padova. All experiments were performed on 2- to 4-month-old male
(28–32g) and female mice (25–28g); mice of the same sex and age were used for
each individual experiment. In vivo transfection experiments were performed by
i.m. injection of expression plasmids in TA muscle followed by electroporation8.
For fasting experiments, control animals were fed ad libitum; food pellets were
removed from the cages of the fasted animals. Denervation was performed by
cutting the sciatic nerve of the left limb, while the right limb was used as control.
Muscles were removed at various time periods after transfection and frozen in
liquid nitrogen for subsequent analyses.
Gene expression analyses. Total RNA was prepared from TA muscles using
Promega SV Total RNA Isolation kit. Complementary DNA (cDNA) generated
with Invitrogen SuperScript III Reverse Transcriptase was analysed by quantitative
real-time RT–PCR using Qiagen QuantiTect SYBR Green PCR Kit. All data were
normalized to GAPDH and actin expression. The oligonucleotide primers used are
shown in Supplementary Table 1.
Plasmids and antibodies for Western blot. In vivo transfection experiments used
the yellow ﬂuorescent protein (YFP)–LC32 and Fbxo21SMART-V5 plasmids. For
the cloning of mouse Fbxo21/SMART gene, muscle cDNA was ampliﬁed by PCR
using the primers forward: 30-ACCATGGCGTCGGTAGCGGGGGACA-50 and
reverse: 30-CTCGGCTGTGTCCTCCTTTGCACTG-50 .
The ampliﬁed sequence was cloned into pcDNA3.1/V5-His TOPO TA
(Invitrogen) expression vector and sequenced. The list of the antibodies is
described in Supplementary Table 2.
Uncropped blots are shown in Supplementary Fig. 19.
In vivo RNAi. In vivo RNAi experiments were performed using at least three
different sequences for each gene(Invitrogen BLOCK-iTTM Pol II miR RNAi
Selected). The sequences are shown in Supplementary Table 3. For the validation of
shRNA constructs, MEF cells were maintained in DMEM/10% FBS and transfected
with shRNA constructs using Lipofectamine 2000 (Invitrogen). Cells were lysed
24 h or 48 h later and immunoblotting was performed.
Gene expression proﬁling. For each of the 4 conditions (FoxO1,3,4f/f fed or
starved and FoxO1,3,4 / fed or starved), we collected the gastrocnemius muscles
of three mice thus yielding six muscles per condition.
RNA was prepared from these muscles using the TRIzol method (Life
Technologies) followed by cleanup with the RNeasy kit (Qiagen). RNA
concentration was determined by spectrophotometry and quality of the RNA was
monitored using the Agilent 2100 Bioanalyzer (Agilent Technologies). RNA of the
six muscles per condition was pooled equimolarly and used for further microarray
analysis. cRNA was prepared, labelled and hybridized to Affymetrix Mouse
Genome 430 2.0 Arrays using Affymetrix-supplied kits and according to standard
Affymetrix protocols. Expression values were summarized using the Mas 5.0
algorithm. Genes that were up or downregulated on starvation compared with the
fed condition were determined using Excel software. A threshold of 1.5 was used
for the fold up or downregulation consistent with the fold change that can be
reliably detected with these type of arrays.
In vivo ChIP assay. We performed ChIP assay in adult skeletal muscles using the
Magna ChIP A/G Chromatin Immunoprecipitation Kit (Millipore)2,28. Soluble
chromatin was co-immunoprecipitated with rabbit polyclonal anti-FKHRL1
(FoxO3) sc-11351X (Santa Cruz Biotechnology), rabbit polyclonal anti-FKHR
(FoxO1) sc-11350X (Santa Cruz Biotechnology) or an equal amount of normal
rabbit IgG, sc-2027 (Santa Cruz Biotechnology). After decrosslinking of the DNA,
samples were subjected to quantitative RT–PCR. The oligonucleotide primers used
are shown in Supplementary Table 4. The regions of ampliﬁcation contain the
FOXO-binding sites for the promoter studied.
Immunoblotting and IP. Frozen gastrocnemius muscles were powdered by pestle
and mortar and lysed in a buffer containing 50mM Tris pH 7.5, 150mM NaCl,
5mM MgCl2, 1mM DTT, 10% glycerol, 2% SDS, 1% Triton X-100, Roche Com-
plete Protease Inhibitor Cocktail, 1mM PMSF, 1mM NaVO3, 5mM NaF and
3mM b-glycerophosphate. The lysis buffer used for MEF and C2C12 cells con-
tained 50mM Tris pH 7.5, 150mM NaCl, 5mM MgCl2, 1mM DTT, 10% glycerol,
1mM EDTA, 0.5% Triton X-100 and the protease inhibitors listed above. Alter-
natively, lysis buffer contained 50mM Tris HCl pH 7.2, 250mM NaCl, 2% NP40,
0.1% SDS, 0.5% sodium deoxycholate 2.5mM, EDTA pH8 with anti-phosphatase
and anti-protease. The samples were immunoblotted and visualized with Super-
Signal West Pico Chemiluminescent substrate (Pierce). Blots were stripped using
Restore Western Blotting Stripping Buffer (Pierce) according to the manufacturer’s
instructions and reprobed if necessary. For Myosin analysis, gastrocnemius muscles
were homogenized in myosin extraction buffer containing 1M Tris pH 6.8, 10%
SDS and 80% glycerol. SDS–PAGE was performed using polyacrylamide gel with a
high glycerol concentration, which allows the separation of MYH isoforms.
Myosins were identiﬁed with Coomassie blu staining.
For co-IP experiment C2C12 muscle cell lines were transfected with V5-
SMART, HA-Skp1, FLAG-Cul1 and FLAG-Roc1 expression plasmids. After 24 h,
cells were lysed in a buffer containing 50mM Tris pH 7.5, 100mM NaCl, 5mM
MgCl2, 1mM DTT, 0.5% Triton X-100, protease and phosphatase inhibitors.
About 1mg of total protein was incubated at a ratio of 1:100 with the mouse
monoclonal anti-FLAG antibody or non speciﬁc mouse IgG along with 30 ml of
Protein A/G PLUS-Agarose sc-2003 (Santa Cruz Biotechnology) overnight at 4 C.
The beads were then washed three times with PBS plus Roche Complete Protease
Inhibitor Cocktail 1X and were ﬁnally resuspended in 30 ml LDS Sample Buffer 1
(NuPAGE Life Technolohy) and 50mM DTT to be further analysed by Western
blotting.
Histology and microscopy. Cryosections of transfected TA muscles were exam-
ined in a ﬂuorescence microscope Leica DM5000B equipped with a Leica DFC300-
FX digital charge-coupled device camera by using Leica DC Viewer software.
Cryosections of TA were stained for haematoxilin and eosin and as well as for
Succinate dehydrogenase and Periodic acid-Schiff. Cross-sectional area was mea-
sured using ImageJ software in at least 400 transfected ﬁbres and compared with
the area of age-matched control.. The ﬁbre diameter was calculated as caliper
width, perpendicular to the longest chord of each myoﬁbre. The total myoﬁbre
number was calculated from entire muscle section based on assembled mosaic
image ( 20 magniﬁcation). Fibre typing was determined by immunoﬂuorescence
using combinations of the following monoclonal antibodies: BA-D5 that recognizes
type 1 MyHC isoform and SC-71 for type 2A MyHC isoform. Images were cap-
tured using a Leica DFC300-FX digital charge-coupled device camera by using
Leica DC Viewer software, and morphometric analyses were made using the
software ImageJ 1.47 version.
LC3-vesicle quantiﬁcation. Cryosections of fed and 30-h fasted muscles from
control and FoxO1,3,4 / mice that were transfected in vivo with YFP–LC3 were
examined using an epiﬂuorescence Leica DM5000B microscope equipped with a
Leica DFC300-FX digital charge-coupled device camera by using Leica DC Viewer
software. The ﬂuorescent dots were counted and normalized for cross-sectional
area.
Autophagic ﬂux quantiﬁcation. We monitored autophagic ﬂux in 30 h of star-
vation using colchicine15. Brieﬂy MLC FoxO1,3,4 / and FoxO1,3,4f/f mice were
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms7670
12 NATURE COMMUNICATIONS | 6:6670 | DOI: 10.1038/ncomms7670 |www.nature.com/naturecommunications
& 2015 Macmillan Publishers Limited. All rights reserved.
treated with 0,4mg kg 1 colchicine or vehicle by i.p. injection and starved. The
treatment was repeated at 15 h prior to muscle harvesting.
Adenovirus production and myotube transfection. FOXO3 was cloned into a
shuttle vector pAdTrack-CMV, which contains green ﬂuorescent protein (GFP)
under the control of a separate promoter. C2C12 mouse myoblasts were cultured in
DMEM 10% FCS until the cells reached conﬂuence. The medium was then
replaced with DMEM 2% horse serum (‘differentiation medium’) and incubated for
4 days to induce myotube formation before proceeding with experiments. For
infection, myotubes were incubated with adenovirus at a multiplicity-of-infection
of 250 in differentiation medium for 18 h, and then the medium was replaced. The
infection efﬁciency was typically 490%.
Muscle physiology. To determine force and contraction kinetics of gastro-
cnemius, mice were anesthetized by a mixture of Xylor and Zoletil, and a small
incision was made from the knee to the hip, exposing the sciatic nerve. Before
branching of the sciatic nerve, TeﬂonTM-coated 7 multistranded steel wires
(AS 632; Cooner Sales, Chatsworth, CA, USA) were implanted with sutures on
either sides of the sciatic nerve. To avoid recruitment of the ankle dorsal ﬂexors the
common peroneal nerve was cut. Torque production of the stimulated plantar
ﬂexors was measured using a muscle lever system (Model 305C; Aurora Scientiﬁc,
Aurora, ON, Canada).
Ex vivo force measurements on soleus muscles were performed by dissecting it
from tendon to tendon under a stereomicroscope and subsequently mounting
between a force transducer (KG Scientiﬁc Instruments, Heidelberg, Germany) and
a micromanipulator-controlled shaft in a small chamber, in which oxygenated
Krebs solution was continuously circulated and temperature was maintained at
25 C. The stimulation conditions were optimized, and the length of the muscle
was increased until force development during tetanus was maximal.
Data were analysed using the PowerLab system (4SP, ADInstruments) and
software (Chart 4, ADInstruments). The sciatic nerves were stimulated using
supramaximal square wave pulses of 0.1-ms duration. Force generation capacity
was evaluated by measuring the absolute maximal force that was generated during
isometric contractions in response to electrical stimulation (frequency of 75–
150Hz, train of stimulation of 500ms). Maximal isometric force was determined at
L0 (length at which maximal tension was obtained during the tetanus). Force was
normalized to the muscle mass as an estimate of speciﬁc force. Following force
measurements, animals were killed by cervical dislocation and muscles were
dissected, weighed and frozen in liquid nitrogen or in isopentane precooled in
liquid nitrogen.
Statistical analysis and general experimental design. The sample size was
calculated using size power analysis methods for a priori determination based on
the s.d., and the effect size was previously obtained using the experimental methods
employed in the study. For animal studies, we estimated sample size from expected
number of knockout mice and littermate controls, which was based on mendelian
ratios. We calculated the minimal sample size for each group by at least four
organisms. Considering a likely drop-off effect of 10%, we set sample size of each
group at ﬁve mice. To reduce the s.d., we minimized physiological variation by
using homogenous animals with same sex and same age. The exclusion criteria for
animals were pre-established. In case of death, cannibalism or sickness, the animal
was excluded from analysis. Tissue samples were excluded in cases such as cryo-
artefacts, histological artefacts or failed RNA extraction. We included animals from
different breeding cages by random allocation to the different experimental groups.
Animal experiments were not blinded, however, when applicable, the experi-
menters were blinded to the nature of samples by using number codes until ﬁnal
data analysis was performed. Statistical tests were used as described in the ﬁgure
legends and were applied on veriﬁcation of the test assumptions (for example,
normality). Generally, data were analysed by two-tailed Student’s t-test. For all
graphs, data are represented as means±s.e.m. For the measurement variables used
to compare KO animals versus controls, or innervated animals versus denervated
ones, the variance was similar between the groups.
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